[125I]GR231118 [7675]



[125I]GR231118

No image available
SMILES CC[C@H](C)[C@H](N)C(O)=N[C@H]1CCC(O)=NC[C@@H](C(O)=N[C@@H](Cc2ccc(O)cc2)C(O)=N[C@@H](CCCNC(=N)N)C(O)=N[C@@H](CC(C)C)C(O)=N[C@@H](CCCNC(=N)N)C(O)=N[C@@H](Cc2ccc(O)cc2)C(=N)O)N=C(O)[C@@H]2CCCN2C(=O)[C@H](N=C(O)[C@@H](N)[C@@H](C)CC)CCC(O)=NC[C@H](C(O)=N[C@@H](Cc2ccc(O)cc2)C(O)=N[C@@H](CCCNC(=N)N)C(O)=N[C@@H](CC(C)C)C(O)=N[C@@H](CCCNC(=N)N)C(O)=N[C@@H](Cc2ccc(O)cc2)C(=N)O)N=C(O)[C@@H]2CCCN2C1=O
InChIKey RJRBRCCJETZJLT-VHUVHYDGSA-N

Chemical Properties

Hydrogen bond acceptors 30
Hydrogen bond donors 38
Rotatable bonds 58
Log P 8.763
Molecular weight (Da) 2351.3
Stereochemistry info partial
Radioactive 125I


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

[125I]GR231118

No image available

Drug properties

Molecular type Protein
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.